Aquestive Therapeutics News - July 10, 2026
🔴 Aquestive Therapeutics Inc is trading 5.66% down
AQST is trading at $4.00, down 5.66%.
Aquestive Bets Its Future on a Postage-Stamp-Sized Allergy Drug — But Can $160 Million in Fresh Capital Buy an FDA Yes?
Shares of Aquestive Therapeutics surged 9.3% in pre-market trading to $4.63, as investors renewed their focus on two financing deals designed to bankroll the...
🟢 Aquestive Therapeutics is trading 9.3% up today following SEC filing for warrant share resale
Aquestive Therapeutics is trading 9.3% up at $4.63 in pre-market sessions, following an SEC filing on July 9, 2026, for the registration of 230,271 warrant...